Joshua Horvath, Ph.D.Director, Early Stage Device Development at Genentech
Josh Horvath is a Director with Genentech Device Development in South San Francisco, California. He joined Genentech in 2013 and manages a team of engineers and scientists responsible for early stage device development and human factors engineering. Prior to joining Genentech, Josh spent seven years with Becton Dickinson in variety of R&D and product development roles, including continuous blood glucose monitoring, pen injection devices, and insulin infusion. He is listed as an inventor on 30 issued patents and is the author or co-author of 13 peer-reviewed journal articles. Josh holds a B.S. in Chemical Engineering from the University of Florida and a Ph.D. in Chemical Engineering from Carnegie Mellon University.